Mutant IDH1 Inhibitor Ivosidenib (IVO; AG-120) in Combination with Azacitidine (AZA) for Newly Diagnosed Acute Myeloid Leukemia (ND AML)
DiNardo CD., Stein AS., Stein EM., Fathi AT., Frankfurt O., Schuh AC., Doehner H., Martinelli G., Raffoux E., Tan P., Zeidan A., de Botton S., Kantarjian HM., Stone RM., Lam D., Wang X., Gong J., Kapsalis SM., Hickman D., Zhang V., Winkler T., Daigle S., Vyas P.